Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
11 Jan 2017 | North America | Market Research
Global Cell Banking Market Trends, Opportunities, and Future
As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding the
This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...
$1,500.00 -
02 Feb 2017 | Europe | Market Research
European Next-generation Sequencing Services Market, Forecast to 2023
Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth
The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...
$4,950.00 -
14 Feb 2017 | North America | Market Research
Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market
Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...
$1,500.00 -
14 Mar 2017 | North America | Market Research
Game-changing Strategies of Leading US Pharma Companies
Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth
The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...
$1,500.00 -
23 Mar 2017 | Asia Pacific | Market Research
APAC Molecular Diagnostics Market, Forecast to 2021
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth
The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...
$4,950.00 -
29 Mar 2017 | Europe | Market Research
Biosimilars Market, Europe, Forecast to 2025
A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter
Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...
$4,950.00 -
20 Apr 2017 | Asia Pacific | Market Research
The Philippines Transformational Healthcare Insights, 2016
Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage
The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...
$1,500.00 -
19 Jun 2017 | Asia Pacific | Market Research
Growth Opportunities in the APAC IVD Market, Forecast to 2021
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market
The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...
$4,950.00 -
22 Jun 2017 | Asia Pacific | Market Research
Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022
Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia
Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...
$1,500.00 -
31 Oct 2017 | Global | Market Research
Global Digital Pathology Market, 2017 Companies-To-Action
Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth
It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...
$3,000.00
